• Latest Posts

UPDATED: TiGenix finishes Phase III Stem Cell therapy to treat Crohn’s disease

Takeda snatches up Belgian Cell therapy for Crohn’s Disease

Key German Hospital to start a Phase I trial in TCR Cell Therapy

Cell Therapy for Heart Failure fails in Phase III … but not Entirely

Will the Leading Italian Biotech soon have its First Cell therapy on the Market?

Could this be the ‘Beginning of the end’ for Diabetes? Let’s Review.

ADVERTISEMENT

Immunotherapy reaches Breakthrough in eliminating HIV

CRISPR Thx in yet another Collaboration, this time for Muscle Dystrophy

Brain Cell Transplant could help with incurable Neurodegenerative Disease

Bone Therapeutics switches to allogeneic for Universal Bone Cell Therapy

Biotech of the Week: Activartis Immuno-Oncology in Vienna

Dutch Startup gets €7M for New Cancer Immunotherapy Platform

ADVERTISEMENT